Gurrent status and progress of neoadjuvant chemotherapy and conversion therapy for locally advanced gastric cancer / 中华消化外科杂志
Chinese Journal of Digestive Surgery
; (12): 1166-1172, 2023.
Article
en Zh
| WPRIM
| ID: wpr-1022415
Biblioteca responsable:
WPRO
ABSTRACT
Gastric cancer is one of the common malignant tumors in China. Among all gastric cancer patients, locally advanced gastric cancer (LAGC) accounts for a high proportion. For this group of patients, the efficacy of surgery alone is limited, and the risk of postoperative recur-rence is high. With the continuous development of therapy mode, various clinical trials and new treatment concepts have emerged, leading to a shift in treatment approaches of LAGC from the previous single chemotherapy to various combination therapies and other novel treatment moda-lities, with the aim to improve efficacy and extend survival of patients. The authors review the current status and progress of neoadjuvant chemotherapy and conversion therapy for LAGC.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Digestive Surgery
Año:
2023
Tipo del documento:
Article